Navigation Links
Final agenda available for CRF Conference on Stem Cell Therapy for Heart Disease
Date:1/8/2014

WHAT:

The final agenda for the Conference on Cell Therapy for Cardiovascular Disease, sponsored by the Cardiovascular Research Foundation, is now available online at http://www.crf.org/celltherapy/the-conference/agenda. The conference, which will be held January 22-24, 2014, is the premier meeting dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke.

This year's conference will focus on preclinical and clinical studies and their paths toward optimizing outcomes. The most promising molecular, cellular, and tissue products will be presented. Presentations of key activities at state, federal, and international levels will also be highlighted as measures of the progress ahead.

WHY:

Recent advances in stem cell research demonstrate great potential as breakthrough therapies for conditions like diabetes, Parkinson's and heart disease. Now in its 13th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has provided both a strong foundation for the conduct of large scale, pivotal studies, as well as insights into mechanisms of cardiovascular repair that will enhance the design of further investigation.

Renowned thought leaders in this field will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies. Sessions will focus on:

  • Molecular and Cellular Pathways: Regulating Biologic Function
  • Mechanistic Insights and Hypothesis
  • Moving Toward Tissue as Therapy: Micro- and Macro-Structure Strategies
  • STEMI and Acute Injury Studies
  • Chronic Injury and Vascular Insufficiency
  • Chronic Left Ventricular Dysfunction and Heart Failure
  • Patients-In-Need: Defining and Refining our Approach to Target Populations
  • Data in Hand: Looking for Answers in Meta-Analytic Studies
  • Clinical Science and Pivotal Studies: Durable Partnerships in Regenerative Medicine

WHO:

Course Director

Warren Sherman, MD
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

Course Co-Directors

Jozef Bartunek, MD, PhD

Henricus J. Duckers, MD, PhD

Amit Patel, MD, MS

Marc S. Penn, MD, PhD

Thomas Povsic, MD

Gordana Vunjak-Novakovic, PhD

Joseph Wu, MD, PhD

Wojtek Wojakowski, MD, PhD

WHEN:

January 22-24, 2014

WHERE:

Vivian and Seymour Milstein Family Heart Center
Myrna L. Daniels Auditorium
NewYork-Presbyterian Hospital/Columbia University Medical Center
New York, NY

For more information visit: http://www.crf.org/celltherapy.

HOW TO REGISTER:

Media may apply for registration by emailing jromero@crf.org.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related biology news :

1. Planet under Pressure conference, London: Final statement
2. Sequencing works in clinical setting to help -- finally -- get a diagnosis
3. NYBG press publishes final volume of landmark Intermountain Flora series
4. Finalists of air pollution sensor challenge announced
5. Dark matter made visible before the final cut
6. Researchers attack HIVs final defenses before drug-resistant mutations emerge
7. WPI Biomedical Technology in final 4 of international business plan contest
8. Final chapter to 60-year-old blood group mystery
9. Fueling fitness on the final frontier
10. Finally mapped: The brain region that distinguishes bits from bounty
11. The Sackler Institute unveils a global research agenda for nutrition science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... Hill, N.C. (PRWEB) , ... June 27, 2016 ... ... U.S. commercial operations for Amgen, will join the faculty of the University ... serve as adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS ... the launch of their brand, UP4™ Probiotics, into Target stores nationwide. The company, ... proud to add Target to its list of well-respected retailers. This list includes ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
Breaking Biology Technology: